Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.41 |
| ▸ | EDNRA | P25101 | 11/20 | 0.40 |
| ▸ | EDNRB | P24530 | 10/20 | 0.40 |
| ▸ | PTGDR2 | Q9Y5Y4 | 3/20 | 0.35 |
| ▸ | NQO2 | P16083 | 1/20 | 0.33 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.33 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7018582 | 0.76 | HCRTR2 (0.36) | PTGS1PTGS2PTGDR2 | |
| SCHEMBL7100609 | 0.75 | CYP11B1 (0.31) | PTGS2 | |
| SCHEMBL7108605 | 0.74 | PTGS2 (0.47) | PTGS1PTGS2 | |
| SCHEMBL7019518 | 0.73 | GRM2 (0.36) | EDNRA | |
| SCHEMBL6406090 | 0.70 | GABRA1 (0.45) | PTGS1PTGS2EDNRAEDNRBMTNR1A | |
| SCHEMBL6413376 | 0.70 | GABRA1 (0.45) | PTGS1PTGS2EDNRAEDNRBMTNR1A | |
| SCHEMBL7022958 | 0.68 | GAA (0.47) | — | |
| SCHEMBL6094036 | 0.68 | PTGS2 (0.86) | PTGS1PTGS2 | |
| SCHEMBL6093313 | 0.68 | PTGS2 (0.86) | PTGS1PTGS2 | |
| SCHEMBL1845395 | 0.66 | PTGDR2 (0.49) | PTGDR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1274700-A1 | DIHYDROBENZOPYRANS, DIHYDROBENZOTHIOPYRANS, AND TETRAHYDROQUINOLINES FOR THE TREATMENT OF COX-2-MEDIATED DISORDERS | Pharmacia Corporation (US) | 2003-01-15 | — | — | EP | disclosed |
| WO-2001049675-A1 | DIHYDROBENZOPYRANS, DIHYDROBENZOTHIOPYRANS, AND TETRAHYDROQUINOLINES FOR THE TREATMENT OF COX-2-MEDIATED DISORDERS | PHARMACIA CORPORATION (US) | 2001-07-12 | — | — | WO | disclosed |